Pitt Street Research

Cynata

Cynata

Cynata (ASX:CYP)

Cynata is a regenerative medicine company.  Its Cymerus technology can produce vast quantities of Mesenchymal Stem Cells from a single blood donation. Cymerus is now in Phase 1 in acute Graft vs Host Disease.  Japan’s Fujifilm has optioned this indication.